MHRAapproval72% confidence
Guidance: COVID-19 test validation approved products
Source: MHRA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to YARTEMLEA.
Regulatory Analysis
Find out which COVID-19 test products have been approved.
Supporting Context
- Therapeutic area
- Hematology · Thrombotic Microangiopathy
- Sub-indication
- General
Related signal: FDA Drug Trials Snapshot: YARTEMLEA Approved for TA-TMA